Skip to main content
. 2015 Nov 23;7(Suppl 1):13–31. doi: 10.4137/TOG.S30534

Figure 4.

Figure 4

Therapeutic strategies targeting the HGF-MET signaling pathway in cancer include HGF activation inhibitors, HGF inhibitors, MET antagonists and MET kinase inhibitors.